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Abstract 
We describe 2 cases of children with malig-
nant disease who developed severe mucositis
with  perineal  necrotizing  fasciitis  during
severe  neutropenia  after  chemotherapy.
Treatment with topical negative pressure ther-
apy with silver foam dressing, together with
large spectrum antibiotics, resolved the prob-
lem with complete closure of the wound after
30 and 36 days of treatment, respectively.
Introduction
We describe 2 cases of children with malig-
nant disease who developed severe mucositis
with perineal necrotizing fasciitis (NF) during
severe  neutropenia  after  chemotherapy.
Treatment with topical negative pressure ther-
apy with silver foam dressing, together with
large spectrum antibiotics, resolved the prob-
lem with complete closure of the wound after
30  and  36  days  of  treatment,  respectively.
Necrotizing fasciitis is a rare event in pedi-
atric  patients.  However,  several  cases  have
been  reported  in  literature  in  children  with
malignant disease.
Case Report #1
A 20-day old female (birth weight 2943g.)
was admitted to our Neonatal Intensive Care
Unit immediately after birth due to the pres-
ence of red-violaceous nodules on the whole
body area and bone marrow aplasia. Histology
of skin biopsy documented acute monoblastic
leukemia (AML) treated according to the pro-
tocol  for  pediatric  AML.  During  the  neu-
tropenic phase after chemotherapy, she pre-
sented severe mucositis in the perineal area
and  oral  mucosa.  Despite  broad-spectrum
antibiotics  and  G-CSF  therapy  the  perineal
lesion  rapidly  progressed  into  necrotizing
fasciitis  with  culture  positivity  for
Pseudomonas Aeruginosa; blood cultures were
negative. The perineal lesion reached 18 cm2
of  square  area  and  a  rectum  prolaxation
appeared. Treatment included large spectrum
iv antibiotics, IVIG, total parenteral nutrition
and  inotropic  drugs,  and  morphine  iv.
Antibiotics were modified according to culture
results.  Local  surgical  debridement  of  the
eschar and application of polyurethane foam
dressings  were  initially  carried  out,  but
because  of  the  lack  of  improvement  of  the
lesion and the persistence of swab positivity to
Pseudomonas, treatment with a topical nega-
tive pressure device with GranuFoam Silver®
dressing (V.A.C, KCI, San Antonio, TX, USA)
was applied on the wound.1 To achieve a uni-
form pressure gradient the foam was covered
by  polyurethane  film.  Topical  negative  pres-
sure started at -50 mmHg and gradually rose to
-75 mmHg. A total of 30 days of negative pres-
sure treatment were required for closure of the
lesion area; the anorectoplasty of the rectum
was performed several months later.
Case Report #2
A 14-month boy with stage IV neuroblastoma
underwent  chemotherapy  according  to  the
SIOP NB-AR 01 study. After his third cycle of
therapy during the severe neutropenia phase
(WBC  0.28¥109/L)  he  developed  a  perineal
lesion  and  fever.  No  previous  mucositis
skin/mucosal lesions nor diarrhea were pres-
ent.  After  the  appearance  of  the  lesion,  the
patient promptly started iv antibiotic therapy
with  ceftazidime  and  amikacina,  and  G-CSF.
Total  parenteral  nutrition  was  necessary.  C-
reactive protein (CPR) rose from 0.71 to 11.8
mg/dL within 12 h. A large area of inflammation
with  redness  and  hot  skin  together  with
intense pain developed over 12-24 h. After 36 h
the inflammation area of the skin and subcuta-
neous tissue showed fast enlargement spread-
ing across the fascial plane of the perineum
and the right gluetal region until the internal
femoral region. Blood culture was negative, as
were swabs of the necrotic areas. After a few
days,  the  patient  needed  surgical  curettage
with  removal  of  eschar  and  necrotic  tissue.
Given  the worsening and enlargement of the
lesion, treatment with a topical negative pres-
sure  device  with  GranuFoam  Silver® was
applied on the wound. The negative pressure
was  gradually  increased  until  -100  mmHg
which  the  patient  tolerated  well.  The  wound
was medicated every 2-3 days under sedation.
To reduce contamination of the area, urinary
and rectal catheters were in place until resolu-
tion.  None  of  the  cultures  performed  during
curettage were able to identify a microorgan-
ism related to the lesion. Despite normalization
of WBC, the patient did not show any improve-
ment of the perineal lesion for several days; 36
days of topical negative pressure therapy were
required to completely close the wound.
Discussion
Necrotizing fasciitis is a rare event in pedi-
atric  patients.  However,  several  cases  have
been reported in literature in children affect-
ed by malignancies, and it is well known that
several predisposing factors may be involved
in the pathogenesis of NF, such as injuries,
immunodepression, and surgical procedures.2-
4 Although Staphyloccus Aureus is recognized
as  the  most  common  cause  of  NF;  other
microorganism such as gram negative bacte-
ria may be responsible for the disease also in
children.5 Prompt  diagnosis  and  adequate
treatment are mandatory. Treatment includes
large  spectrum  iv  antibiotics,  intravenous
immu  noglobulin, as well as surgical debride-
ment  and  removal  of  the  necrotic  eschar.5
Topical  negative  pressure  is  a  procedure
which  has  been  recently  introduced  in  the
management  of  the  wound  and  has  proved
useful in accelerating its closure due to the
stimulation  of  granulation  tissue,  and
improved  angiogenesis  process  and  blood
flow.6 In our experience, topical negative ther-
apy was well tolerated by the patients. In par-
ticular, it allowed constant debridement and
removal of debris and secretions, and kept the
wound  area  clean  when  other  conventional
techniques had failed to achieve wound clo-
sure. 
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